Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine and Caffeine + Diet in Morbid Obesity
NCT02048215Phase 3Completed
- Sponsor
- Istituto Auxologico Italiano
- Start
- Feb 2000
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ephedrine, caffeine in obesity, sponsored by Istituto Auxologico Italiano. Started Feb 2000; status: completed.
02
Drugs
ephedrinecaffeine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02048215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048215.